de Beaufort, Eloïse
Carteaux, Guillaume
Morin, François
Lesimple, Arnaud
Haudebourg, Anne-Fleur
Fresnel, Emeline
Duval, Damien
Broc, Alexandre
Mercat, Alain
Brochard, Laurent
Savary, Dominique
Beloncle, François
Mekontso Dessap, Armand
Richard, Jean-Christophe
Article History
Received: 7 April 2023
Accepted: 22 June 2023
First Online: 4 July 2023
Declarations
:
: The clinical study was approved by the institutional ethical committee of the French Intensive Care Society as a component of standard care. Patient consent was waived.
: Not applicable.
: G. Carteaux reports personal fees from Air Liquide Medical System and Löwenstein, outside the submitted work. E. de Beaufort is a PhD student in Med<sub>2</sub>Lab which is partially funded by Air Liquide Medical Systems. A. Lesimple is a PhD student in Med<sub>2</sub>Lab which is partially funded by Air Liquide Medical Systems. A. Broc reports a salary from Air Liquid Medical Systems. D. Savary reports personal fees from Air Liquide Medical Systems. F. Beloncle reports personal fees from Löwenstein Medical, Air Liquide Medical Systems, and research support from Covidien, GE Healthcare and Getinge Group, outside this work. A. Mercat reports personal fees from Faron Pharmaceuticals, Air Liquide Medical Systems, Pfizer, Resmed and Draeger, and grants and personal fees from Fisher and Paykel and Covidien, outside this work. A. Mekontso Dessap reports grants from Fischer Paykel, Baxter, Philips, Ferring and GSK, personal fees from Air Liquide, Baxter, Amomed, Getingue and Addmedica, outside the submitted work. JC Richard reports part time salary for research activities (Med<sub>2</sub>Lab) from Air Liquide Medical Systems and Vygon. All other authors declare no competing interests.